v3.26.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Deficit)
Beginning balance (in shares) at Jun. 30, 2023   2,277,828      
Beginning balance at Jun. 30, 2023 $ (36,730) $ 114 $ 66,764 $ 9,023 $ (112,631)
Increase (Decrease) in Stockholders' Equity          
Net income 91,060       91,060
Foreign currency translation (Note 1) (321)     (321)  
Stock-based compensation 1,622   1,622    
Recognition of deferred compensation (Note 11) (118)     (118)  
Net restricted stock activity (in shares)   2,120      
Net restricted stock activity (18)   (18)    
Common stock issued in connection with Alline Acquisition 0        
Stock warrants issued in connection with debt [1] 1,292   1,292    
Ending balance (in shares) at Jun. 30, 2024   2,279,948      
Ending balance at Jun. 30, 2024 56,787 $ 114 69,660 8,584 (21,571)
Increase (Decrease) in Stockholders' Equity          
Net income 123,536       123,536
Foreign currency translation (Note 1) (177)     (177)  
Stock-based compensation 1,413   1,413    
Recognition of deferred compensation (Note 11) (121)     (121)  
Net restricted stock activity (in shares)   15,481      
Net restricted stock activity (74) $ 1 (75)    
Common stock issued in connection with Alline Acquisition (in shares) [2]   140,552      
Common stock issued in connection with Alline Acquisition [2] 3,000 $ 7 2,993    
Stock warrants issued in connection with debt [1] $ 1,252   1,252    
Ending balance (in shares) at Jun. 30, 2025 2,435,981 2,435,981      
Ending balance at Jun. 30, 2025 $ 185,616 $ 122 75,243 8,286 101,965
Increase (Decrease) in Stockholders' Equity          
Net income 6,943       6,943
Foreign currency translation (Note 1) $ (556)     (556)  
Exercise of stock options (in shares) 49,000 24,564      
Exercise of stock options $ 607 $ 1 606    
Stock-based compensation 1,175   1,175    
Recognition of deferred compensation (Note 11) (113)     (113)  
Net restricted stock activity (in shares)   25,666      
Net restricted stock activity (159) $ 1 (160)    
Common stock issued in connection with Alline Acquisition 0        
Common stock issued in connection with warrant exercise (in shares)   12,567      
Common stock issued in connection with warrant exercise $ 299 $ 1 298    
Ending balance (in shares) at Jun. 30, 2026 2,498,778 2,498,778      
Ending balance at Jun. 30, 2026 $ 193,812 $ 125 $ 77,162 $ 7,617 $ 108,908
[1] This activity represents the stock warrants issued in connection with the new credit facility agreement and amendment. Stock warrant value shown net of allocated financing costs. See Note 8 and Note 14 for additional details.
[2] This activity represents the common stock issued in connection with the Alline Acquisition on December 19, 2024. See Note 16 for additional details.